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Autonomic influences on the heart have been recognized for
many centuries. It was not until 1921, however, that a
German physiologist named Otto Loewi stimulated a frog’s
vagus nerve, collected the released substance, and applied it
to a second, different frog heart to demonstrate its effects.
For his discovery of this “vagusstuff” (subsequently shown to
be acetylcholine), Loewi (1) shared the 1936 Nobel Prize in
Physiology or Medicine. We now know that acetylcholine
released by the vagus nerve is the predominant parasympa-
thetic influence on the heart while epinephrine and norepi-
nephrine mediate the principal cardiac sympathetic effects (2).
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The measurement of autonomic tone in humans nonin-
vasively presented new challenges. Subtle beat-to-beat vari-
ations in heart rate are influenced by autonomic tone, giving
rise to the measure of heart rate variability (HRV). That
changes in the RR-interval (heart rate) precede and predict
clinically relevant events was first appreciated in the mid-
1960s when beat-to-beat variations in heart rate were shown
to portend fetal distress (2). Later, it was appreciated that
reduced HRV was an independent predictor of ventricular
arrhythmias, sudden cardiac death, and total mortality after
myocardial infarction and predicted increased mortality in
other patient populations such as those with heart failure or
diabetes (2–4).
Experimental studies utilizing vagus nerve stimulation,
vagotomy, and muscarinic receptor blockade have demon-
strated that efferent vagal activity contributes significantly to
the high-frequency (HF) component of HRV (2). While
interpretation of the low-frequency (LF) component of
HRV is more controversial, most agree that at least some
portion reflects sympathetic modulation of the autonomic
nervous system (2). The LF/HF ratio is viewed by many,
therefore, to represent sympathovagal “balance” (2). Impor-
tantly, HRV measures changes in the relative degree of
autonomic modulation of heart rate, not the absolute level
of sympathetic or parasympathetic tone.
In this issue of the Journal, Amar et al. (5) report the
results of their investigation into the autonomic fluctuations
preceding the development of postoperative atrial fibrilla-
tion (AF) in patients undergoing major thoracic surgery.
They utilized HRV measures as an indicator of autonomic
tone. Compared with control patients, those who developed
AF had an increase in LF and HF power and a decrease in
LF/HF ratio in the period preceding AF onset. These
findings are consistent with activation of both the sympa-
thetic and parasympathetic systems with a shift towards
parasympathetic predominance. These findings add to the
growing body of literature suggesting that autonomic influ-
ences play an important role in the initiation of AF.
A number of other studies have also demonstrated that
fluctuations in autonomic tone, as measured by HRV,
precede the onset of AF (6–10). Yet while these investiga-
tions consistently demonstrate that dynamic changes in
autonomic tone occur prior to AF, the frequency, character,
and degree of change varies considerably from study to
study. For example, among patients with structurally normal
hearts, some have observed an increase in vagal predomi-
nance in the minutes preceding AF onset, while others have
noted a marked shift towards sympathetic predominance
(10,11). Other patients with paroxysmal AF or AF triggered
by pulmonary vein foci may experience a rise in sympathetic
tone followed by a marked shift towards vagal predomi-
nance in the minutes preceding AF onset (6,7), findings
more consistent with those of Amar et al. In contrast,
patients undergoing cardiac surgery experience a relative
decrease in vagal tone and an increase in sympathetic tone
before developing AF (9). To explain these various obser-
vations, some have suggested that vagally mediated AF
occurs most often in patients with normal hearts and occurs
predominantly at night when vagal tone is relatively high,
while adrenergically induced AF occurs more frequently in
patients with organic heart disease and occurs more fre-
quently during the day (11). However, not all studies
support this simplified interpretation of the data. Indeed,
there are many exceptions to this “rule.”
A number of important electrophysiologic changes occur
in atrial myocardium in response to an increase in vagus
nerve activity. Acetylcholine, acting via its effect on musca-
rinic receptors, reduces the slope of spontaneous depolar-
ization of the sinoatrial node pacemaker cells and results in
a slowing of the heart rate. Acetylcholine also shortens the
atrial refractory period and increases the heterogeneity of
atrial refractoriness, effects that predispose to reentry
(12,13). It appears that the relative sympathovagal balance is
as important, or more important, than the absolute sympa-
thetic or parasympathetic tone. Indeed, experimental re-
gional cardiac denervation (e.g., withdrawal of sympathetic
tone from a specific atrial site) can result in a relative
increase in vagal tone without a change in the absolute vagal
tone. This can result in regional shortening of the atrial
refractory period, heterogeneity of atrial repolarization, and
predisposition to induction of AF (14–16). This important
interplay between sympathetic and parasympathetic tone is
further underscored by the observation that AF induction in
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dogs occurs much more readily with infusion of isoproter-
enol and acetylcholine than with either isoproterenol or
acetylcholine alone (17).
That increased vagal tone can predispose to the develop-
ment of AF has been recognized since the initial description
by Coumel et al. (18). Perhaps most exciting are the new
therapeutic avenues that have been opened by our increased
understanding of the autonomic influences that predispose
to AF. Parasympathetic ganglia have been localized to
discrete epicardial fat pads. Radiofrequency ablation of
specific fat pads causes regional alterations of cardiac para-
sympathetic tone and, as a result, affects atrial refractory
periods, atrioventricular nodal conduction properties, and
heterogeneity of atrial conduction (15,19,20). In dogs,
catheter ablation of parasympathetic nervous input to the
atrium can abolish vagally mediated AF (21).
Loewi’s (1) initial description of “vagusstuff” opened the
door to important advances in our understanding of cardiac
autonomic regulation. Similarly, improved understanding of
the autonomic influences that predispose to AF will be
critical to the development of novel therapies. While there
is much that remains to be learned, specific pharmacologic,
catheter, or device-based therapies that alter or regulate
autonomic tone may someday prove to be useful weapons in
the battle against AF.
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